Status:
COMPLETED
Study of CM310 in Healthy Subjects
Lead Sponsor:
Keymed Biosciences Co.Ltd
Conditions:
Healthy
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
This is a single center, randomized, double-blind, placebo-controlled, dose escalation study.
Eligibility Criteria
Inclusion
- Healthy male volunteers.
- aged ≥ 18 and ≤ 65 years old.
- With all clinical laboratory examination normal.
- Voluntary signing of the informed consent form.
Exclusion
- With a history of asthma and allergic reactions.
- With a history of conjunctivitis and keratitis, as well as previous medical conditions.
- With positive results from alcohol breath or urine drug abuse testing.
Key Trial Info
Start Date :
September 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 13 2020
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06161090
Start Date
September 3 2019
End Date
January 13 2020
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PKUCare Luzhong Hospital
Zibo, China